BBR may reduce IR in rats with non-alcoholic fatty liver disease (NAFLD) by increasing IRS-2 mRNA and protein levels (Xing et al., 2011). The gene discussed is IRS2; the disease is metabolic dysfunction-associated steatotic liver disease.